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1. Introduction 
The rapid clearance of intravenously infused lyso- 
somal enzymes appears to be a general phenomenon 
in the rat. These enzymes are predominantly glyco- 
proteins and specific recognition sites on their carbo- 
hydrate moieties are apparently involved in mediating 
the rapid clearance process [l]. Presumably, subtle 
structural differences in the nature of the oligosac- 
charide fragment of these enzymes are capable of 
greatly modifying or even eliminating the binding 
reaction and subsequent clearance from the blood [2]. 
The isolation and characterization of an hepatic 
membrane protein which specifically recognizes and 
binds the terminal galactosyl residues of glycoproteins 
has been described [3,4]. The binding protein appears 
to be responsible for the rapid and selective hepatic 
clearance of desialylated glycoproteins from the cir- 
culation [2]. An avian hepatic binding protein which 
recognizes and binds specifically to serum glycopro- 
teins bearing terminal non-reducing N-acetylglucosa- 
mine residues has also been identified and isolated 
[.5,6]. However, no such hepatic receptor has been 
isolated from mammals. The rapid plasma clearance 
of lysosomal glycosidases eems to be mediated by 
liver plasma membrane binding sites or receptors with 
subsequent endocytosis [7]. Evidence suggests that 
these lysosomal enzymes localize in Kupffer cells and 
that a substantial part of the clearance is mediated by 
a mannose recognition system. Both mannans and 
N-acetylglucosamine terminated glycoproteins can 
inhibit uptake of lysosomal enzymes by the liver [8]. 
In order to elucidate the mechanism of hepatic 
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uptake of lysosomal acid hydrolases, the clearance of 
intravenously infused native and desialylated gluco- 
cerebrosidase by rat hepatocytes and Kupffer cells 
has been studied [9]. Their findings indicated that 
intact glucocerebrosidase iscleared by both hepatocytes 
and Kupffer cells and that removal of sialic acid from 
the enzyme markedly increased its uptake by hepato- 
cytes with a corresponding decrease in uptake by 
Kupffer cells after intravenous infusion. Furthermore, 
agalacto-orosomucoid was found [ 1,7] to block the 
clearance of a variety of rat lysosomal enzymes which 
are normally cleared rapidly following infusion. These 
findingsled them to attribute clearance of the lysoso- 
ma1 hydrolases to the system described for agalacto- 
orosomucoid and to suggest hat the terminal N-acetyl- 
glucosamine was part of the recognition site on the 
enzyme which mediated clearance. 
These results and propo&ls prompted us to inves- 
tigate the importance of hepatocytes and Kupffer 
cells in mediating clearance of glucocerebrosidase 
from which both sialic acid and galactose had been 
enzymatically cleaved. 
2. Materials and methods 
2 .l . Infusion enzymes 
The preparation of human placental glucocerebro- 
sidase and its desialylated form have been described 
previously [9,10]. The agalacto enzyme was prepared 
by reacting purified /3-galactosidase [ 1 l] with asialo- 
glucocerebrosidase. In a typical preparation, lo-20 fi 
5.5 pmol/min/ml /3-galactosidase were incubated with 
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0.6-l 5 X 10” units asialoglucocerebrosidase 
(390-900 yg protein) in 50 mM citrate-phosphate 
buffer, pH 6.5. Because of the relatively small amount 
of P-galactosidase with respect to that of the gluco- 
cerebrosidase, the two enzymes were not separated 
prior to infusion. Incubation with /I-galactosidase 
caused no loss of glucocerebrosidase activity. 
2.2. Enzyme assays 
Enzyme activities were determined as in [lo] and 
are expressed as nmol glucocerebroside hydrolyzed/h. 
Activities in cell preparation were obtained by assay 
of detergent-buffer extracts in which a known quan- 
tity of hepatocytes or Kupffer cells (5 X lo6 cells) 
was sonicated in 0.5 ml 15 mM phosphate, pH 6.0, 
containing 10 mg/ml sodium taurocholate and 2 mg/ml 
cutscum. 
2.3. Enzyme infusion 
Male Osborne-~endel rats were anesthetized by 
injecting sodium pentobarbit~ intraperitone~ly. The 
femoral vein and artery were cannulated for enzyme 
infusion and blood sampling, respectively. Agalacto- 
enzyme, -600 000 units, were infused to measure 
plasma half-life, while 650 000 units were infused 
to study liver uptake. To determine whether the clear- 
ance of agalacto-glucocerebrosidase could be inhibited 
by another agalacto-~ycoprotein~ ag~acto-fetuin, 
5 mg, was administered intravenously 2 min before 
infusion of agalacto-glucocerebrosidase. 
2.4. Isolation of hepatocytes 
Modifications of the method of Berry and Friend 
for the preparation ofisolatedliver cells were as in [9]. 
In short, the apparatus and liver perfusion technique 
were as in [ 121 modified ] I3]. Calcium-free Krebs- 
Henseleit buffer was used as the perfusate. No 
hyaluronidase was added. No adjustment of pH was 
needed with a gas phase of 95% 0~5% COZ. A per- 
fusion rate of 20-25 ml/min was used. 
Total recovery ranged from 25-50 X 1 O7 hepato- 
cytesirat liver perfused. From SO-90% of the cells 
excluded Trypan blue. Contamination by non-paren- 
chymal cells was < 1%. 
2 5. Isolation of Kupffer cells 
The isolation technique was essentially as in [9]. 
The initial cell suspension was prepared in Krebs- 
Henseleit solution. A single solution of Metrizamide 
was used at final cont. 16% (w/v). The purified non- 
parenchymal cells which included Kupffer cells were 
recovered by pipette from the Metrizamide-buffer 
interface. Kupffer cells present in the suspension were 
identified by their ability to phagocytize latex and 
carbon particles as well as their ability to bind to 
immunoglobulin (IgG) coated sheep red blood cells 
[ 14,151. Using these parameters, -25% of the cells 
were identified as Kupffer cells and the remainder as 
endothelial cells. Total recovery of sinusoidal cells 
ranged from 20-35 X I O6 cells/rat liver perfused. In 
excess of 95% of the cells excluded Trypan blue; con- 
tamination with hepatocytes was < 0.5%. 
3. Results and discussion 
The distribution of intact and enzymatically-modi- 
fied glucocerebrosidase fo~owing intravenous infusion 
is shown in table 1. Infusion of untreated enzyme 
resulted in -7-fold increase in enzyme content by 
Kupffer cells and -2.5fold increase in hepatocyte 
content over baseline 191. Considering that hepato- 
cytes constitute 78% parenchymal volume while 
sinusoidal lining cells constitute only 6% in the rat 
[ 161, it is evident that the majority of the infused 
enzyme is taken up by hepatocytes. Infusion of asialo- 
glucocerebrosidase [9] resulted in an appreciably 
larger proportion of enzyme taken up by hepatocytes 
and a correspondingly smaller proportion being taken 
up by Kupffer cells. The present study shows that 
after further enzymatic modification of the enzyme 
by treatment with /3-galactosidase, intravenous infusion 
of the agalacto-enzyme also results in an increased 
~llount of enzynlatic activity in hepatocytes. How- 
ever, in contrast to the results obtained with the asialo- 
enzyme, there is also a marked increase in the uptake 
of the agalactoenzyme by Kupffer cells, the enzymatic 
content of these cells being 2.5~times greater than that 
of corresponding cells from control animals. 
Figure 1 shows plasma disappearance curves of 
intact and agalacto-~u~ocerebrosidase. The clearance 
of the modified enzyme was 14-times faster than that 
of the native glucocerebrosidase. In [9], the clearance 
of asialoglucocerebrosidase was also found to be 
appreciably faster than that of the intact enzyme. 
Figure 1 also shows that the accelerated clearance of 
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Table 1 
Hepatic uptake of glucocerebrosidase 
July 1978 
loo 
90 
60 1 
70 - 
60- 
50- 
P40- 
I 
s 
ii! 
l-xl- 
E 
P 
i! 
20 - 
15 - 
Units 
admin. 
Baseline gluco- 
cerebrosidase (SEM) 
Intact gluco- 
cerebrosidase 
Average (SEM) 
P-Galactosidase and 
neuraminidase-treated 
glucocerebrosidase 
Average (SEM) 
0 
1.0x lo6 
1.0 x lo6 
6.5 x 10’ 
6.5 x lo5 
6.5 x 10’ 
6.3 x lo* 
Enzyme activity 
(units/lo” cells) 
Kupffer cells” Hepatocytes 
6.6 (i 0.9) 103.6 (i 6.4) 
69.0 281 
39.7 240 
34.0 281 
47.6 (* 10.9) 255 (* 13.2) 
191 432 
125 378 
193 328 
169.7 (* 22.3) 379.3 (t 30.0) 
a No distinction between Kupffer cells and other sinusoidal ining cells was made 
in determination of cell number 
agalacto-glucocerebrosidase is completely blocked in 
the presence of excessive agalacto-fetuin. This inhibi- 
tion of clearance tends to confirm that the enzymati- 
tally-modified glucocerebrosidase used in this study 
was the agalacto-derivative. Quantitative carbohydrate 
analyses are currently in progress to determine the 
exact amounts of sialic acid and galactose removed 
from glucocerebrosidase by the enzymatic procedures 
used in this study. 
The recognition system for clearance of agalacto- 
glucocerebrosidase cannot at this time be precisely 
defined. A substantial’ part of the clearance of intact 
lysosomal enzyme from rat plasma may be mediated 
by a mannose recognition system [ 1,8]. A mannan- 
binding protein in rabbit liver has been isolated and 
characterized [ 171. IV-Acetylglucosamine-terminated 
Fig.1. Clearance of glucocerebrosidase from the circulation of 
rats. Results are expressed as a percentage of the first post- 
infusional sample taken. Each point represents the mean 
value from 3 expts. 
(0) Untreated enzyme (T,/, ‘21 min). 
(0) Agalactoenzyme (T,/* 1.5 min). 
(a) Agalactoenzyme + 5 mg agalacto-fetuin (T,/, 32 min). 
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glycoproteins were in fact potent inhibitors of mannan 
binding to this protein. The mannan-binding protein 
was proposed to be the principle mediator of hepatic 
uptake ofN-acetylglucosamine-terminated glycopro- 
teins [ 171. However, the exact role of the mannan 
binding protein in the recognition and uptake of 
lysosomal enzymes remains to be established. 
Several explanations are possible for the observed 
greater uptake of agalacto-glucocerebrosidase by
Kupffer cells than desialylated glucocerebrosidase. 
Kupffer cells may have surface receptor(s) which spe- 
cifically recognize N-acetylglucosamine-terminated 
glycoproteins. Alternatively, there may be further 
enzymatic modification of the enzyme, either by 
Kupffer cell or in the circulation, which renders it 
more susceptible to uptake by Kupffer cells. Unpub- 
lished results from this laboratory suggest he former 
explanation. 
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